A spectrum of CDMO services
Kincell supports the continuum of cell therapy CMC development and manufacturing from early, to late phase, clinical product supply.
Watch our presentation from the Outsourced Pharma Capacity Update 2025 to learn how our integrated CDMO solutions accelerate immune cell therapy development from early-phase to commercial readiness.
Upcoming Event
We’re excited to be attending the BIO International Convention from June 16–19 in Boston! If you’re developing cell therapies, let’s connect. Come learn how we can support your program with flexible, expert-driven solutions from early development through commercial readiness. Looking forward to seeing you in Boston!